Frailty – 7 Interesting Facts
- Frailty is a clinical syndrome resulting from aging-related dysregulation of multiple physiologic systems leading to a loss of physiologic reserve and markedly increased vulnerability to stressors such as acute illness, injury, and medical interventions. This ultimately leads to increased risk of adverse health outcomes
- Frailty exists on a spectrum from prefrailty to mild symptoms to severe limitations and then ultimately failure to thrive and a premorbid state
- 2 major conceptual models of frailty include physical frailty syndrome, defined by physiologic alterations, and deficit accumulation frailty, defined by an accumulation of chronic disorders that can impair functioning and increase vulnerability
- Physical manifestations of frailty include weakness, slowed walking speed, low physical activity, low energy or exhaustion, and weight loss. Balance may be poor and patients have an increased risk of falls
- Diagnosis is based on clinical scoring systems, the most common being the frailty phenotype (or Fried frailty tool) and the frailty index4516
- There are no specific treatments, but effective preventive and treatment interventions include maintaining muscle mass and strength through resistance exercise or a multicomponent exercise program. Dietary protein supplementation may also be beneficial4043
- Management by a multidisciplinary team, when possible, is optimal
Alarm Signs and Symptoms
- Symptoms that may indicate a new life-threatening stressor include:
- Acute worsening weakness
- Decreased food intake
- Falls
- Fever
- Shortness of breath
Introduction
- Frailty is a clinical syndrome of aging-related dysregulation of multiple physiologic systems leading to loss of physiologic reserve and thus markedly increased vulnerability to stressors with increased risk of adverse health outcomes12
- Stressors include acute illness, surgical or medical interventions, and trauma
- Adverse outcomes include procedural complications, falls, institutionalization, disability, and death
- Physical frailty and index frailty are the 2 major conceptual models of frailty
- These models form the basis of frailty measurement tools and diagnosis3
- Physical frailty, also known as phenotypic or syndromic frailty, is a clinical syndrome with 5 components: weight loss, exhaustion, weakness, slowness, and low level of physical activity
- Results from energy dysregulation in multiple systems45
- Physical frailty is the most commonly used definition of frailty6
- Sarcopenia is a loss of muscle mass and strength and is a major component of physical frailty
- Results from energy dysregulation in multiple systems45
- Index frailty, also known as deficit accumulation frailty, defines frailty based on the accumulation of multiple disorders and impairments that each increase the risk of mortality and disability78
- These deficits include disabilities, diseases, physical and cognitive impairments, psychosocial difficulties, geriatric syndromes (eg, falls, delirium, urinary incontinence), and laboratory, imaging, or electrodiagnostic abnormalities
- Rationale for the deficit accumulation model is that the more deficits an individual has, the greater their risk of an adverse health outcome
- The frailty index is a score calculated by adding together the number of impairments and conditions an individual has7
- Frailty exists on a spectrum ranging from prefrailty to frailty to failure to thrive
- Prefrailty refers to people who fulfill some but not all criteria for frailty
- Such people are at risk for developing frailty
- Prefrailty may involve physical or index frailty
- Failure to thrive is a syndrome manifested by decreased appetite, poor nutrition and inactivity associated with weight loss greater than 5% of baseline, cognitive and functional decline, depression, and malnutrition
Epidemiology
- Prevalence of frailty varies with the population studied and frailty instrument used
- A systematic review of prevalence of frailty in adults aged 50 years and older across 62 countries revealed that the pooled prevalence of physical frailty was 12% compared to 24% for index frailty9
- There was significant variability among countries in this review
- Prevalence of physical prefrailty was 46% and 49% for index prefrailty9
- Prevalence of frailty in several studies in the United States ranged from 4% to 16% in community-dwelling males and females aged 65 and older451011
- In general, the prevalence of frailty is higher in females than in males9
- Prevalence of physical frailty was 15% among females and 11% among males
- Prevalence of index frailty was 29% among females and 20% among males
- Prevalence of frailty also increases with age9
- In the Cardiovascular Health Study, prevalence of frailty increased from 3.9% in the age group of 65 to 74 years to 25% in the age group older than 85 years4
- Prevalence has also been found to be higher among people with lower income and lower education and among certain racial and ethnic groups14
- Black participants were more than twice as likely to be frail than White participants in the Cardiovascular Health Study (13% versus 6%) and the Women’s Health and Aging Studies (16% versus 10%)14
- Prevalence of frailty among older Mexican American participants in the Hispanic Established Populations for Epidemiologic Studies of the Elderly was 7.8%, similar to that of White participants12
Etiology and Risk Factors
Etiology
- Can be classified as primary or secondary13
- Both result in similar phenotypes and vulnerabilities to adverse health outcomes
- Primary frailty refers to frailty resulting from aging-related changes in physiologic processes and systems
- Sarcopenia (loss of skeletal muscle mass and strength) is a key component of primary frailty
- Secondary frailty refers to frailty resulting from the effects various specific disorders
Primary Frailty
Figure 1. A model pathway of physical frailty that links biology and disease to physiologic changes and clinical manifestations of physical frailty.From Walston J et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991.
- Primary frailty is thought to result from dysregulation of various physiologic systems (Figure 1),14 particularly those involved with the endocrine system, immune system, and pathways of energy and metabolism14
- The fundamental underlying causes of this dysregulation are still unclear but are thought to involve a combination of:
- Aging-related molecular changes
- Genetic factors
- Environmental factors
- Effects of diseases
- Nutritional deficiencies (low levels of certain vitamins and carotenoids, reduced intake of protein and calories)
- Physiologic abnormalities interact synergistically to increase frailty risk
- The number of abnormalities is a stronger predictor of frailty than the degree of dysfunction of any given system13
Secondary Frailty
- Secondary frailty results from the effects of multiple disorders, which independently contribute to the development of frailty, possibly via:14
- Inflammation
- Diminished cardiopulmonary function
- Physical inactivity
- Contributory disorders include:
- Immunosuppressive disorders (eg, HIV/AIDS)
- Heart failure
- COPD (chronic obstructive pulmonary disease)
- Cancer, particularly lymphoma, multiple myeloma, occult solid tumors
- Chronic kidney disease
- Metabolic syndrome
- Chronic infection (eg, tuberculosis, chronic cytomegalovirus infection, HIV)
Risk Factors
- Many characteristics, comorbidities, and lifestyle factors increase the risk of frailty, including:15
- Cognitive impairment
- Depression
- Drinking
- Female sex
- Hearing impairment
- Higher education level
- History of falls
- Increasing age
- Living alone
- Low levels of exercise
- Lower BMI
- Lower vitamin D levels
- Malnutrition
- Chronic pain
- Polypharmacy
- Sleep disorders
- Smoking
- The following factors can help predict loss of muscle mass and strength with aging:
- Decreased levels of anabolic factors such as testosterone, DHEA-S (dehydroepiandrosterone sulfate) and IGF-1 (insulinlike growth factor 1)
- Decreased physical activity
- Reduced caloric intake and intake of nutrients, including protein and vitamin D and other micronutrients
- Older age
Diagnosis
Approach to Diagnosis
- Frailty assessment may be appropriate to:
- Identify those at risk of adverse medical or surgical outcomes and determine the severity of risk
- Identify those who may benefit from preventive or treatment measures
- Help determine prognosis
- Help guide shared decision-making about care plans and eligibility for palliative care
- An international consensus conference has recommended that older adults be assessed for frailty if they have 1 or more of the following:2
- Age greater than 70 years
- Significant involuntary weight loss (greater than or equal to 5% of body weight) due to chronic illness
- Numerous frailty assessment tools are available and are the basis of frailty diagnosis and screening
- Most frailty instruments are based on either the physical frailty or the deficit accumulation model
- Physical frailty is most often assessed using the physical frailty phenotype (Fried frailty tool) (Table 1)4516
- Assesses 5 components: weight loss, exhaustion, slowness (walking speed), strength, activity level
- Requires active patient participation and specialized equipment for measuring grip strength and gait speed
- Decreased gait speed alone is predictive of adverse outcomes in many settings
- Decreased gait speed and grip strength are early manifestations of frailty and can serve as a marker in screening.
- Deficit accumulation frailty is most often assessed using the (frailty index),78161718 which is based on the accumulation of illnesses, the presence of functional and cognitive decline, and difficulties in daily life (Table 2)
- It requires answering 20 or more medical- and function-related questions regarding symptoms, signs, disabilities, and diseases
- Different question sets can be used; Table 3 lists a representative example
- Some indices also incorporate optional performance measures (eg, grip strength, gait speed)
- The index is the ratio of deficits present to the total number of deficits assessed. For example, if 40 deficits are assessed and 10 are present in a given person, their frailty index is 10/40 = 0.25
- The index also can be calculated based on information available in the medical record without requiring a patient interview or examination
- Calculations can be done manually or digitally from certain electronic health records (electronic frailty index)
- The electronic frailty index can identify older adults with mild, moderate, and severe frailty with robust predictive validity for such outcomes as mortality, hospitalization, and nursing home admission19
- Patients identified as frail or prefrail based on these brief screening tools should have a more detailed clinical evaluation for the impact of frailty such as is done during a comprehensive geriatric assessment,20 which more thoroughly evaluates physical and mental status, functioning, social circumstances, and environment
- Frail patients also should have laboratory testing to identify potential stressors and underlying causes
- Complete blood count
- Comprehensive metabolic panel including liver biochemical tests and albumin
- TSH level
- Vitamin B12 level
- Vitamin D level
- Inflammatory markers, C-reactive protein, and erythrocyte sedimentation rate
- Imaging and other tests are used only as needed to evaluate abnormalities identified on examination or laboratory testing
Table 1. Physical frailty phenotype.*
Frailty criterion | Definition | |
---|---|---|
Unintentional weight loss | Meets criteria for weight loss if: Lost > 5% body weight unintentionally in last year, or BMI < 18.5 kg/m2 Equipment: scale for body weight; stadiometer for height | |
Exhaustion | Meets criteria for exhaustion if answer: Felt unusually tired or unusually weak “all of the time” or “most of the time,” or reported energy level was ≤ 3 using the following questions: 1.a. “In the past month, on the average, have you been feeling unusually tired during the day?” □ Yes □ No □ Refused □ Don’t know 1.b. “If yes, have you been feeling unusually tired?” □ All of the time □ Most of the time □ Some of the time □ Refused/Don’t know 2.a. “In the past month, on the average, have you felt unusually weak?” □ Yes □ No □ Refused □ Don’t know 2.b. “If yes, have you been feeling weak?” □ All of the time □ Most of the time □ Some of the time □ Refused/Don’t know 3. “Using the scale below, please rate your usual energy level on a scale from 0 to 10 where 0 is no energy and 10 is the most energy that you have ever had. Please give a number between 0 and 10 that describes your usual energy level while awake in the last month.” Energy level: ______ | |
Slowness | Meets criteria for slow walking speed over 4 meters if: | |
Males ≤ 0.65 m/s for height ≤ 173 cm (68 in) ≤ 0.76 m/s for height > 173 cm (68 in) | Females ≤ 0.65 m/s for height ≤ 159 cm (63 in) ≤ 0.76 m/s for height > 159 cm (63 in) | |
Equipment: 4-meter course, a stopwatch Participant attempts to walk 4-meter length twice at their own pace. Use average of 2 trials | ||
Low activity level | Meets criteria for low activity if: | |
Males < 128 kcal of physical expenditure on activity scale per week (6 items†) | Females < 90 kcal of physical expenditure on activity scale per week (6 items†) | |
Weakness | Meets criteria for grip strength weakness if: | |
Males ≤ 29 kg for BMI ≤ 24 ≤ 30 kg for BMI 24.1-26 ≤ 30 kg for BMI 26.1-28 ≤ 32 kg for BMI > 28 | Females ≤ 17 kg for BMI ≤ 23 ≤ 17.3 kg for BMI ≤ 23.1-26 ≤ 18 kg for BMI ≤ 26.1-29 ≤ 21 kg for BMI > 29 | |
Equipment: (Jamar) hand dynamometer Participant attempts to squeeze the dynamometer maximally 3 times with the dominant hand. Use maximal score with dominant hand |
Caption: *Scoring: ≥3/5 criteria met indicates frailty; 1-2/5 indicates pre- or intermediate frailty; 0/5 indicates nonfrail.
†Physical activity is based on modified Minnesota Leisure Time Activities Questionnaire, asking about walking (w = 3.5), strenuous household chores (w = 4.5), strenuous outdoor chores (w = 4.5), dancing (w = 5.5), bowling (w = 3.0), and exercise (w = 4.5). To compute kcals expended per week, use the formula: kcals (kilocalories/week) = w × frequency (sessions per week) × duration per session (minutes) × body weight (kg)/60, where w is the task-specific MET intensity score
Data from Fried LP et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146; Bandeen-Roche K et al. Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol A Biol Sci Med Sci. 2006;61:262; and Guidance on selecting a frailty assessment instrument. FrailtyScience.org. Johns Hopkins University. Accessed February 15, 2024. https://frailtyscience.org/frailty-assessment-instruments.
Table 2. Deficit accumulation (frailty) index.*†
Frailty criterion | Definition |
---|---|
Deficits in health | At least 30-40 deficits—defined as symptoms, signs, disabilities, and diseases—should be selected Deficits can be included if:They are associated with health statusThe prevalence of the deficit increases with ageSaturation of the deficit does not occur too early in the life courseThe deficits cover a range of symptoms (eg, deficits are not solely related to cognitionThe same deficits are included when used serially on the same peopleDeficit variables are scored as binary (0 or 1) or can be graded (eg, 0, 0.5, 1) The score is expressed as the ratio of deficits present over the total number of deficits included. For example, if the person has 10 deficits present out of 40 deficits total, the index score would equal 10/40 or 0.25 Examples of deficits include: ‡Restricted activityDisability in Activities of Daily Living and Instrumental ADLImpairments in general cognition and physical performance (eg, impaired grip strength, impaired walking)ComorbiditySelf-rated healthDepression/mood |
Caption: *The deficit accumulation index approach may vary in the type and number of deficits included.
†Scoring: frailty index score of 0.2 or greater recognizes a person as approaching a frail state.
‡See Table 3 for a full list of 40 deficits and their proposed scoring.
Data from Searle SD et al. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24; and Guidance on selecting a frailty assessment instrument. FrailtyScience.org. Johns Hopkins University. Accessed February 15, 2024. https://frailtyscience.org/frailty-assessment-instruments.
Table 3. An example of the frailty index.
Variable | Scoring |
---|---|
Help dressing | Yes = 1 No = 0 |
Help getting in/out of chair | Yes = 1 No = 0 |
Help walking around house | Yes = 1 No = 0 |
Help eating | Yes = 1 No = 0 |
Help grooming | Yes = 1 No = 0 |
Help using toilet | Yes = 1 No = 0 |
Help up/down stairs | Yes = 1 No = 0 |
Help lifting 10 lbs | Yes = 1 No = 0 |
Help shopping | Yes = 1 No = 0 |
Help with housework | Yes = 1 No = 0 |
Help with meal preparations | Yes = 1 No = 0 |
Help taking medication | Yes = 1 No = 0 |
Help with finances | Yes = 1 No = 0 |
Lost more than 10 lbs in last year | Yes = 1 No = 0 |
Self-rating of health | Poor = 1 Fair = 0.75 Good = 0.5 Very Good = 0.25 Excellent = 0 |
How health has changed in last year | Worse = 1 Better/Same = 0 |
Stayed in bed at least half the day due to health (in last month) | Yes = 1 No = 0 |
Cut down on usual activity (in last month) | Yes = 1 No = 0 |
Walk outside (in last month) | <3 days = 1 ≥3 days = 0 |
Feel everything is an effort | Most of time = 1 Sometimes = 0.5 Rarely = 0 |
Feel depressed | Most of time = 1 Sometimes = 0.5 Rarely = 0 |
Feel happy | Most of time = 0 Sometimes = 0.5 Rarely = 1 |
Feel lonely | Most of time = 1 Sometimes = 0.5 Rarely = 0 |
Have trouble getting going | Most of time = 1 Sometimes = 0.5 Rarely = 0 |
High blood pressure | Yes = 1 Suspect = 0.5 No = 0 |
Heart attack | Yes = 1 Suspect = 0.5 No = 0 |
Congestive heart failure | Yes = 1 Suspect = 0.5 No = 0 |
Stroke | Yes = 1 Suspect = 0.5 No = 0 |
Cancer | Yes = 1 Suspect = 0.5 No = 0 |
Diabetes | Yes = 1 Suspect = 0.5 No = 0 |
Arthritis | Yes = 1 Suspect = 0.5 No = 0 |
Chronic lung disease | Yes = 1 Suspect = 0.5 No = 0 |
Mini-Mental Status Examination | <10 = 1 11-17 = 0.75 18-20 = 0.5 20-24 = 0.25 >24 = 0 |
Peak flow (liters per minute) | Male: ≤340 = 1; Female: ≤310 = 1 |
Shoulder strength (kg) | Male: ≤12 = 1; Female: ≤9 = 1 |
BMI | <18.5 or ≥30 = 1 25-<30 = 0.5 |
Grip strength (GS) in kg | Male: BMI ≤24, GS ≤29 = 1 BMI 24.1-28, GS ≤30 = 1 BMI >28, GS ≤32 = 1 Female: BMI ≤23, GS ≤17 = 1 BMI 23.1-26, GS ≤17.3 = 1 BMI 26.1-29, GS ≤18 = 1 BMI >29, GS ≤21 = 1 |
20-foot walk at usual pace (seconds) | >16 seconds = 1 |
20-foot walk at rapid pace (seconds) | >10 seconds = 1 |
Caption: *The FI (frailty index) is the total point score divided by the number of items assessed; this corrects for unavailable information. Thus if a person’s score is 15 and 40 items are assessed, their FI is 15/40 = 0.375. A person with an FI of 0.2 or greater is approaching a frail state.
From Searle SD et al. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24; Table 1.
Diagnostic Criteria
- Although no gold standard for diagnosing frailty exists, scores on the frailty phenotype (Fried frailty tool) (see Table 1)4516 or a frailty index tool (see Table 3)17 are widely used
- The Fried frailty tool is based on the following 5 criteria:4516
- Unintentional weight loss greater than or equal to 5% of body weight or greater than 10 lbs during past year
- Exhaustion: self-report regarding effort required to engage in routine activity during the past week)
- Slow walking speed (gait speed): time to walk 15 feet greater than 6 to 7 seconds. Exact cutoff depends on sex and height
- Low physical activity level (kilocalories spent per week): males expending less than 383 kcals and females less than 270 kcal (calculated from activity scale incorporating household chores, yard work, walking, and so on)
- Weakness: decreased grip strength measured with a hand dynamometer; cutoff depends on sex and BMI
- Frailty is defined as meeting 3 or more criteria
- Prefrailty is defined as meeting 1 to 2 criteria
- Criteria when using the electronic frailty index are:19
- From 0 to 0.12: fit
- From greater than 0.12 to 0.24: mild frailty
- From greater than 0.24 to 0.36: moderate frailty
- Greater than 0.36: severe frailty
- Different criteria are used for various frailty index calculations
- Severe frailty is defined as greater than 0.4 on non-electronic frailty indexes but greater than 0.36 on the electronic frailty index19
Workup
- History and physical examination are the core of evaluation. Laboratory tests and imaging studies are supportive
History
- History often shows evidence of frailty and its causes and complications
- Family members and/or caretakers may need to be questioned
- Symptoms suggesting physical frailty phenotype:
- Weight loss greater than 10 lbs unintentionally in last year
- Fatigue: low energy levels and excessive fatigue
- Inactivity
- Reduced physical activity based on activity scale (see Table 1. Physical frailty phenotype)
- Reported difficulty or inability to do activities of daily living or previously done recreational activities
- Feeling of weakness
- Decreased food intake
- Symptoms of important causes of frailty include:
- Recurrent fever, which may suggest chronic infection
- Diarrhea, which may suggest chronic infection, thyroid disease, cancer
- Weight loss and other symptoms that may be associated with specific cancers
- Dyspnea on exertion, which may suggest heart failure or COPD
- Known disorders particularly associated with frailty that should be assessed on past medical history include:
- COPD
- Immunosuppressive disorders (eg, HIV/AIDS)
- Heart failure
- Cancer, particularly lymphoma, multiple myeloma, occult solid tumors
- Chronic kidney disease
- Metabolic syndrome
- Chronic infection
- Complications of frailty are suggested by history of:
- Falls
- Progressive functional decline
- Surgical complications
- Disability
- Repeated hospitalizations
- Potential stressors that may trigger complications in frail patients that should be sought include:
- Recent acute infection
- Recent acute exacerbation of chronic illness
- Acute injury
- Recent surgical or medical interventions
Physical Examination
- May elicit findings of frailty and of its causes and complications
- Examination findings suggestive of physical frailty include:
- Sarcopenia (decreased muscle mass, muscle strength, and function), which may be noted directly or based on anthropometric measurements202122232425
- Directly noted by observing muscle wasting in the face, shoulders, upper arms, and hands
- BMI less than 18.5
- Calf and mid-upper arm circumference and skinfold thickness1
- Mid-upper arm and calf circumferences have been shown to correlate with overall muscle mass and health and nutritional status and to also predict performance and survival in older people222324
- Circumference values suggesting frailty include mid-upper arm less than 22.5 cm and calf less than 31 cm21
- Skinfold values associated with frailty vary with age and sex
- However, with increasing age, changes in the distribution of fat and loss of skin elasticity make circumference and skinfold measurements less reliable estimates of sarcopenia in older people2425
- Mid-upper arm and calf circumferences have been shown to correlate with overall muscle mass and health and nutritional status and to also predict performance and survival in older people222324
- Decreased muscle strength as indicated by:21
- Handgrip strength on dynamometer
- Depends on gender and BMI (see Table 3)
- Lower limb muscle strength assessed by repeated chair stand test
- Time needed to rise 5 times from a chair to standing more than 15 seconds21
- Handgrip strength on dynamometer
- Balance and gait abnormalities 21
- 4-stage balance test of 4 standing positions:26
- Stand with feet side-by-side
- Stand with the instep of 1 foot touching the big toe of the other foot
- Tandem stance: place 1 foot in front of the other with heel touching toes
- Stand on 1 foot
- Short Physical Performance Battery test21
- Includes gait speed for 4 m plus the above balance test and repeated chair stand test
- 4-stage balance test of 4 standing positions:26
- Deconditioning:4521
- Gait speed (see Table 1)
- Timed Get Up and Go test
- Rise from seated, walk 3 m and back and return to seated position in less than 20 seconds
- Timed stair climb test (varies with age)
- Short Physical Performance Battery test21
- Optional tests for more active people include:
- 6-minute walk test27
- 400-meter walk test2829
- Sarcopenia (decreased muscle mass, muscle strength, and function), which may be noted directly or based on anthropometric measurements202122232425
- Physical findings suggestive of underlying causes of frailty include:
- Dyspnea, wheezes, rhonchi: suggestive of COPD
- Weight loss, lymphadenopathy: suggestive of immunosuppressive disorders (eg, HIV/AIDS)
- Peripheral edema, jugular venous distention, abnormal heart sounds, heart murmur: suggestive of heart failure
- Weight loss, lymphadenopathy, hepatomegaly, splenomegaly, palpable tumor: suggestive of cancer, particularly lymphoma, multiple myeloma, occult solid tumors
- Ascites, peripheral edema, jaundice, spider angiomas, splenomegaly, asterixis: suggestive of chronic liver disease
- Dry skin, changes in mental status, peripheral edema: may suggest chronic kidney disease and/or vitamin deficiency
Laboratory Tests
- Laboratory testing to identify potential stressors and rule out treatable conditions includes:
- Complete blood count
- Comprehensive metabolic panel including liver biochemical tests and albumin
- TSH level
- Vitamin B12 level
- Vitamin D level
- Cultures, serology, and other testing for potential infectious illnesses if indicated by findings on history and examination
Imaging Studies
- Imaging studies should be done as needed to confirm underlying disorders suspected based on history and examination
- Imaging studies also can assess muscle mass when done for other clinical reasons (or for research purposes)
- DXA30
- CT or MRI3132
Other Diagnostic Tools
- A very large number of frailty assessment tools have been developed and are in use
- The most widely used tools include:
- Frailty phenotype (or Fried frailty tool, see Table 1)4516
- Frailty index (see Table 3)78161718
- Frailty index is considered a more sensitive predictor of adverse health outcomes than the Fried frailty tool8
- Other rapid screening/assessment tests have been developed for ease of use in clinical settings:
- Interview-based FRAIL scale33
- Study of Osteoporotic Fractures tool34
- Edmonton Frailty Scale35
- Clinical Frailty Scale36
- Modified Frailty Index3738
Differential Diagnosis
- Several disorders cause manifestations similar to those of frailty. These disorders are often known by history but may be undiagnosed
Table 4. Differential Diagnosis: Frailty.
Condition | Description | Differentiated by |
---|---|---|
Cardiovascular disease: heart failure | Patients with heart failure, particularly at the end stage, may present with symptoms of frailty such as weakness, fatigue, and/or weight loss (other than weight gain from volume overload during acute exacerbations) | May be differentiated by other accompanying symptoms such as shortness of breath, orthopnea, dependent edema, laboratory and imaging findings |
COPD | Patients with end-stage COPD may present with symptoms of frailty such as weakness, fatigue, and/or weight loss | May be differentiated by other accompanying symptoms such as shortness of breath on exertion and at rest, wheezing, typical physical examination findings, imaging findings and pulmonary function tests |
Depression | Depression may be associated with feelings of weakness, limited physical activity, and poor food intake | May be differentiated by a positive depression screen and absence of objective features of physical frailty (eg, decreased muscle mass, weakness on strength testing, impaired balance and gait) |
Drug adverse effects, particularly from polypharmacy | Older adult patients are more susceptible to drug adverse effects and often have prescriptions for similar drugs from multiple providers, often resulting in symptoms of frailty such as weakness, fatigue, balance and gait disturbances, and decreased physical activity | May be identified by medication reconciliation and frequent drug review (eg, using Beers criteria39) and absence of objective features of physical frailty (eg, decreased muscle mass, weakness on strength testing, impaired balance and gait) May require a trial of withdrawal from therapy |
Endocrinologic disease, particularly hyper- or hypothyroidism, diabetes mellitus | Patients with these endocrinologic diseases may present with symptoms of frailty such as weakness, fatigue, and/or weight loss | Thyroid disorders may be differentiated by presence of symptoms such as weight gain, tremors, myxedema, or proptosis. Endocrine disorders also lack objective features of physical frailty (eg, decreased muscle mass, weakness on strength testing, balance and gait abnormalities) Laboratory tests such as TSH, blood sugar, and HbA1C are diagnostic |
Hematologic disease, particularly myelodysplasia, iron deficiency, and vitamin B12 deficiency anemia | Patients with hematologic disorders may present with symptoms of frailty such as weakness and fatigue | May be differentiated by absence of objective features of the physical frailty syndrome (eg, decreased muscle mass, weakness on strength testing, balance and gait abnormalities) Laboratory tests including blood tests and bone marrow biopsy also help diagnose these disorders |
Malignancy, particularly lymphoma, multiple myeloma, occult solid tumors | Patients with malignancies often present with symptoms of frailty either from the malignancy itself or as a result of treatment, including weakness, exhaustion, and/or weight loss | May be differentiated by accompanying symptoms, physical features, and laboratory and imaging findings suggestive of malignancy |
Neurologic disease, particularly Parkinson disease, vascular dementia | Patients with neurologic disorders may present with features of frailty such as weakness, fatigue, and/or balance and gait abnormality | May be differentiated by accompanying symptoms, physical features such as tremor, focal rather than generalized weakness, extrapyramidal manifestations, and/or cognitive impairment May also be differentiated by absence of some objective features of the physical frailty syndrome (eg, decreased muscle mass, weakness on strength testing, weight loss) |
Renal disease: renal insufficiency | Patients with renal failure, particularly at the end stage, may present with symptoms of frailty such as weakness, fatigue, and/or weight loss | May be differentiated by laboratory and imaging findings |
Rheumatologic disease, particularly polymyalgia rheumatica, vasculitis | Patients with rheumatologic diseases may present with symptoms of frailty such as weakness, fatigue, and/or weight loss | May be differentiated by other accompanying symptoms such as joint pains, predominantly proximal muscle weakness, vasculitic skin rash, elevated ESR and CRP |
Caption: COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; HbA1C, glycated hemoglobin A1C.
Treatment
Approach to Treatment
- No specific treatments for frailty exist
- The task force of the ICFSR (International Conference on Frailty and Sarcopenia Research) has clinical practice guidelines for the identification and management of frailty (Table 5)40
- The focus of care for frail patients should be to:404142
- Treat any modifiable precipitating causes of frailty
- Establish goals of care with the patient and family
- Improve the clinical manifestations of frailty, especially to:
- Increase physical activity and strength
- Improve exercise tolerance
- Improve nutrition
- Minimize the effects of stressors such as acute illness or injury
- A team-based, multidisciplinary approach including a geriatric care specialist, physical therapist, occupational therapist, pharmacist, and nutritionist can help optimize outcome and preserve independence43
- Multidisciplinary approach has a positive impact on:43
- Avoiding polypharmacy
- Preventing falls
- Improving functional status
- Decreasing need for nursing-home admission
- Reducing mortality
- Multidisciplinary approach has a positive impact on:43
- Goals of care and treatment plans are guided by frailty scales and scores
- Goals of care should be based on shared decision-making between patients and health care providers, taking into account each patient’s goals as well as their life expectancy
- Goals should be reviewed periodically, especially when there is a change in frailty status, so that management options continue to reflect life expectancy and patient preferences
- Palliative care or hospice may be appropriate for patients with severe frailty, depending on their preferences
- An interdisciplinary team approach is particularly important to ensure all components of palliation are provided, including easing symptoms, supporting psychosocial and spiritual needs, and improving quality of life4445
Table 5. International Conference on Frailty and Sarcopenia Research recommendations for frailty screening, assessment and management.
Recommendation | Grade | Certainty of evidence | |
---|---|---|---|
Frailty screening | |||
1 | All adults aged 65 years and over should be offered screening for frailty using a validated rapid frailty instrument suitable to the specific setting or context | Strong | Low |
Frailty assessment | |||
2 | Clinical assessment of frailty should be performed for all older adults screening as positive for frailty or prefrailty | Strong | Low |
Development of a comprehensive management plan | |||
3 | A comprehensive care plan for frailty should systematically address polypharmacy, the management of sarcopenia, treatable causes of weight loss, and the causes of fatigue (depression, anemia, hypotension, hypothyroidism, and vitamin B12 deficiency) | Strong | Very Low |
4 | Where appropriate, persons with advanced (severe) frailty should be referred to a geriatrician | CBR | No data† |
Physical activity/exercise | |||
5 | Older people with frailty should be offered a multicomponent physical activity program (or those with prefrailty as a preventative component) | Strong | Moderate |
6 | Health practitioners are strongly encouraged to refer older people with frailty to physical activity programs with a progressive, resistance-training component | Strong | Moderate |
Nutrition and oral health | |||
7 | Protein/caloric supplementation can be considered for persons with frailty when weight loss or undernutrition has been diagnosed | Conditional | Very Low |
8 | Health practitioners may offer nutritional/protein supplementation paired with physical activity prescription | Conditional | Low |
9 | Advise older adults with frailty about the importance of oral health | CBR | No data† |
Pharmacological intervention | |||
10 | Pharmacologic treatment as presently available is not recommended therapy for the treatment of frailty | CBR | Very Low |
Additional therapies and treatments | |||
11 | Vitamin D supplementation is not recommended for the treatment of frailty unless vitamin D deficiency is present | CBR | Very low |
12 | Cognitive or problem-solving therapy is not systematically recommended for the treatment of frailty | CBR | Very low |
13 | Hormone therapy is not recommended for the treatment of frailty | CBR | Very low |
14 | All persons with frailty may be offered social support as needed to address unmet needs and encourage adherence to the Comprehensive Management Plan | Strong | Very low |
15 | Persons with frailty can be referred to home-based training | Conditional | Low |
Caption: CBR, consensus-based recommendation.
From Dent E et al. Physical frailty: ICFSR international clinical practice guidelines for identification and management. J Nutr Health Aging. 2019;23:771-787, Table 1.
Nondrug and Supportive Care
Figure 2. Potential interventions along the spectrum of frailty in older adults.ACE, acute care for elders unit; GEM, geriatric evaluation and management; PACE, program for all-inclusive care of the elderly. Walston J et al. Frailty screening and interventions: considerations for clinical practice. Clin Geriatr Med. 2018;34(1):25-38, Figure 1.
- Interventions vary depending on where patients fall along the continuum of frailty (Figure 2)46
- A systematic review of the effectiveness of interventions to prevent progression of prefrailty and frailty in older adults summarized 21 randomized trials with a total of 5275 older adults and 33 interventions43
- Exercise and nutrition interventions were among the most successful interventions
- Group exercise sessions were more successful than one-to-one training sessions
- Exercise
- A progressive exercise program beginning with flexibility and balance training and followed by resistance and endurance training has been shown to be effective in improving physical function43
- For frail, sedentary people with safety concerns or those with difficulty adhering to a program, a gradual increase of exercise intensity is important
- For this population, the American College of Sports Medicine guidelines recommend that resistance and/or balance training should precede aerobic training47
- Resistance (strengthening) exercise is a key component of frailty treatment and prevention4048495051
- Can be done alone or as part of a multicomponent exercise program
- Has been found to increase strength and function with few adverse health outcomes
- Walking is recommended for aerobic exercise and training balance
- Optimal frequency, intensity, and time of exercise is not yet known
- A progressive exercise program beginning with flexibility and balance training and followed by resistance and endurance training has been shown to be effective in improving physical function43
- Nutritional support, particularly protein-calorie supplementation,4043 is beneficial particularly when combined with exercise
- Manal et al summarized 4 types of nutritional intervention:52
- Specific nutritional supplements
- Daily food fortification with protein supplement
- Nutritional education and counseling
- Supplementation of micronutrients including vitamin D, ω-3 fatty acids, and multivitamins
- Manal et al summarized 4 types of nutritional intervention:52
- The person’s residential environment and support services should be evaluated to ensure they can live there safely and comfortably
- Social support services should be engaged as needed, including meal delivery services, and home aides to provide personal care40
- Alternative living arrangements (eg, assisted-living facilities, living with a family member) may need to be considered for people whose living situation is incompatible with their degree of frailty
- Regarding palliative care, models such as PATH (Palliative and Therapeutic Harmonization) are standardized systems for frail patients that provide a structured approach to medical and surgical decision-making in older adults and improve patient/family experience and resource utilization in frailty53
Drug Therapy
- Current medications should be reviewed to identify polypharmacy and contributors to weight loss and exhaustion40
- Specific drugs of particular concern as causes of weight loss include metformin, acarbose, miglitol, pramlintide, liraglutide, exenatide, zonisamide, topiramate, bupropion, and fluoxetine54
- Drug classes that may cause feelings of fatigue and exhaustion include tricyclic antidepressants, first generation antihistamines, benzodiazepines, β-blockers, muscle relaxants, opioid analgesics, antiepileptics, and chemotherapeutic agents
- The Beers criteria39 are a helpful guide to evaluating medication use in older adults
- No pharmacologic therapy is currently helpful in treatment of frailty40
- Despite findings that low serum levels of 25-hydroxyvitamin D (less than 20.0 ng/mL) were associated with a higher prevalence of frailty,55 no large-scale study has demonstrated that vitamin D supplementation has a significant effect on frailty
- Several meta-analyses of randomized trials do show a reduction in falls with vitamin D supplementation,5657585960 along with improvement in balance and preservation of muscle strength61
- Similarly, replacing deficiencies of any one hormone or repleting defects in other systems as a sole intervention have not demonstrated a significant treatment effect on frailty
- However, a multicomponent intervention that involves hormone replacement in a deficiency state such as hypothyroidism in addition to other measures such as nutrition and exercise would be helpful4042
- Androgen supplementation with atamestane (an aromatase inhibitor that increases testosterone secretion in males) and/or DHEA (a testosterone precursor) has not demonstrated a significant treatment effect on males with frailty62
Admission Criteria
- Hospital admission is not necessary for frailty itself although treatment of causes of frailty may require hospitalization
- The ability of frail patients to reside at home or whether they require assisted living or nursing home care depends on:
- Their functional status
- The availability of family members and/or other caregivers to provide the necessary support and assistance
- Patients with even moderate to severe functional decline may reside at home if family and/or other caregivers are available and capable of providing support
- Other patients, particularly those with significant functional decline and dependency on others for basic activities of daily living, may require an assisted-living facility or nursing home
Follow-Up
Monitoring
- Patients with prefrailty or who are identified as frail should have a comprehensive geriatric assessment and management combined with ongoing expert geriatric care and periodic reevaluation466364
- Individually tailored interventions based on impairments identified by the comprehensive geriatric assessment may be beneficial in reducing functional decline4665
- Goals of care should be reviewed periodically, especially when there is a change in frailty status and/or life expectancy, to ensure patients and family clearly understand their management options
Complications
- Patients with frailty are at increased risk of procedural complications, falls, institutionalization, disability, and death
- As frailty progresses, other geriatric syndromes, including cognitive impairment, delirium, falls, incontinence, pressure injury, and functional decline, may also become apparent
Prognosis
- Frailty is associated with progressive functional decline and increasing dependency at the end of life
- Frailty is associated with increased mortality
- Mortality was increased in those with baseline frailty (HR [hazard ratio] 1.71; 95% CI 1.48-1.97) In the longitudinal Women’s Health Initiative Observational Study10
- Mortality was twice as high for frail males, compared with robust males in another study on males (HR 2.05; 95% CI 1.55-2.72)11
- Severe frailty, with 4 or 5 syndrome characteristics in the frailty phenotype, and metabolic abnormalities of low cholesterol and albumin predict high short-term mortality rates in frail older adults66
- These characteristics can be considered a predeath phase in severely frail adults who responded poorly to treatment
- A palliative approach may be appropriate for such patients if it is consistent with their goals of care
- Frailty index has been shown to be superior in predicting mortality compared to the frailty phenotype67
- Frailty index is strongly correlated with the risk of death (correlation coefficient greater than 0.95)67
- As people approach a frailty index of 0.7, their chance of survival is greatly diminished44
- One report suggested that 100% of those who have a frailty index greater than 0.5 die within about 20 months6869
Referral
- Patients with frailty should be referred to a physical activity program40
- Patients with advanced frailty should be referred for expert geriatric care40
Screening and Prevention
Screening
- An international consensus conference has recommended that adults be screened for frailty if they have at least 1 of the following:2
- Age older than 70 years
- Significant involuntary weight loss (greater than or equal to 5% of body weight) with chronic illness
- ICFSR clinical practice guidelines recommend that all adults aged 65 years and older be offered screening for frailty (see Table 5)40
- However, routine frailty screening has not been conclusively shown to reduce mortality and morbidity related to frailty240
Prevention
- Minimize frailty precipitants and their associated stress by promptly identifying and treating:
- Acute infections
- Acute exacerbations of chronic illnesses such as heart failure and COPD exacerbation
- Acute injury
- Hormonal deficiencies
- Acute exacerbations of chronic pain
- Medications
- Maintaining physical activity, muscle mass, and strength is a cornerstone of prevention
- Resistance, or strengthening, exercise is effective in increasing muscle mass, strength, and walking speed in frail older adults43
- Other forms of exercise, including stretching, tai chi, and aerobic exercise, are also helpful to improve physical function43
- Overall, exercise has proven beneficial physiologic effects on sarcopenia, inflammation, and other systems associated with frailty43
- Consumption of a Mediterranean diet, including supplementation of protein, calories, and micronutrients as needed, lowered the risk of becoming frail in community-dwelling adults aged 65 years and older4370717273
Author Affiliations
Ugochi Ohuabunwa, MD
Department of Medicine
Geriatrics and Gerontology
Emory University
References
1.Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med. 2011;27(1):1-15.
View In Article|Cross Reference
2.Morley JE et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392-397.
View In Article|Cross Reference
3.Theou O et al. Operationalizing frailty using the frailty phenotype and deficit accumulation approaches. Interdiscip Top Gerontol Geriatr. 2015;41:66-73.
View In Article|Cross Reference
4.Fried LP et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146
View In Article|Cross Reference
5.Bandeen-Roche K et al. Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol A Biol Sci Med Sci. 2006;61:262.
View In Article|Cross Reference
6.Lacas A et al. Frailty in primary care: a review of its conceptualization and implications for practice. BMC Med. 2012;10:4.
View In Article|Cross Reference
7.Kiely DK et al. Validation and comparison of two frailty indexes: the MOBILIZE Boston Study. J Am Geriatr Soc. 2009;57:1532.
View In Article|Cross Reference
8.Rockwood K et al. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62:738-743.
View In Article|Cross Reference
9.O’Caoimh R et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing. 2021;50(1):96-104.
View In Article|Cross Reference
10.Woods NF et al. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc. 2005;53:1321.
View In Article|Cross Reference
11.Cawthon PM et al. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc. 2007;55:1216.
View In Article|Cross Reference
12.Graham JE et al. Frailty and 10-year mortality in community-living Mexican American older adults. Gerontology. 2009;55(6):644-651.
View In Article|Cross Reference
13.Martinchek M. Frailty in the Geriatric Review Syllabus. A Core Curriculum in Geriatric Medicine. 11th ed. American Geriatrics Society; 2022.
14.Walston J et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991.
View In Article|Cross Reference
15.Wang X et al. Risk factors for frailty in older adults. Medicine. 2022;101(34):e30169.
View In Article|Cross Reference
16.Guidance on selecting a frailty assessment instrument. FrailtyScience.org. Johns Hopkins University. Accessed February 15, 2024.
View In Article|Cross Reference
17.Mitnitski AB et al. Accumulation of deficits as a proxy measure of aging. Scientific World J. 2001;1:323-336.
View In Article|Cross Reference
18.Searle SD et al. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24. PMID
View In Article|Cross Reference
19.Clegg A et al. Development of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353-360.
View In Article|Cross Reference
20.Beaudart C et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016;16:170.
View In Article|Cross Reference
21.Guttikonda D et al. Sarcopenia assessment techniques. Clin Liver Dis (Hoboken). 2021;18(4):189-192.
View In Article|Cross Reference
22.Landi F et al. Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Nutr. 2010;29:441–447.
View In Article|Cross Reference
23.Landi F et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr. 2014;33:539-44
View In Article|Cross Reference
24.Rolland Y et al. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003;51:1120-1124.
View In Article|Cross Reference
25.Heymsfield SB et al. Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr. 1982;36:680-690.
View In Article|Cross Reference
26.The 4-Stage Balance Test. Centers for Disease Control and Prevention. Accessed February 15, 2024.
View In Article|Cross Reference
27.Boxer R et al. The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure. Congest Heart Fail. 2010;16(5):208-213.
View In Article|Cross Reference
28.Vestergaard S et al. Characteristics of 400-meter walk test performance and subsequent mortality in older adults. Rejuvenation Res. 2009;12(3):177-184.
View In Article|Cross Reference
29.Krumpoch S et al. Short distance analysis of the 400-meter walk test of mobility in community-dwelling older adults. Gait Posture. 2021;88:60-65.
View In Article|Cross Reference
30.Visser M et al; Health, Aging, and Body Composition Study–Dual-Energy X-ray Absorptiometry and Body Composition Working Group. Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-free mass and leg muscle mass. J Appl Physiol. 1999;87:1513-1520.
View In Article|Cross Reference
31.Mitsiopoulos N et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. 1998;85:115-122.
View In Article|Cross Reference
32.Levine JA et al. Measuring leg muscle and fat mass in humans: comparison of CT and dual-energy X-ray absorptiometry. J Appl Physiol. 2000;88:452-456.
View In Article|Cross Reference
33.Morley JE et al. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16(7):601-608.
View In Article|Cross Reference
34.Ensrud KE et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med. 2008;168(4):382-389.
View In Article|Cross Reference
35.Rolfson DB et al. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006;35(5):526-529.
View In Article|Cross Reference
36.Rockwood K et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489-495.
View In Article|Cross Reference
37.Tsiouris A et al. A modified frailty index to assess morbidity and mortality after lobectomy. J Surg Res. 2013;183:40-46.
View In Article|Cross Reference
38.Subramaniam S et al. New 5-factor modified frailty index using American College of Surgeons NSQUIP data. J Am Coll Surg. 2018;226:173-181.
View In Article|Cross Reference
39.2023 American Geriatrics Society Beers Criteria Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081.
View In Article|Cross Reference
40.Dent E et al. Physical frailty: ICFSR international clinical practice guidelines for identification and management. J Nutr Health Aging. 2019;23:771-787.
View In Article|Cross Reference
41.Chen X et al. Frailty syndrome: an overview. Clin Interv Aging. 2014;9:433-441.
View In Article|Cross Reference
42.Allison R et al. Frailty: evaluation and management. Am Fam Physician. 2021;103(4):219-226.
View In Article|Cross Reference
43.Apóstolo J et al. Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review. JBI Database System Rev Implement Rep. 2018;16(1):140-232.
View In Article|Cross Reference
44.Koller K et al. Frailty in older adults: Implications for end-of-life care. Cleve Clin J Med. 2013;80(3):168-174.
View In Article|Cross Reference
45.Raudonis BM et al. Frailty: an indication for palliative care. Geriatr Nurs. 2010;31:379-384.
View In Article|Cross Reference
46.Walston J et al. Frailty screening and interventions: considerations for clinical practice. Clin Geriatr Med. 2018;34(1):25-38.
View In Article|Cross Reference
47.Chodzko-Zajko WJ et al. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc. 2009;41:1510-1530.
View In Article|Cross Reference
48.Daley MJ et al. Exercise, mobility and aging. Sports Med. 2000;29:1.
View In Article|Cross Reference
49.Spirduso WW et al. Exercise dose-response effects on quality of life and independent living in older adults. Med Sci Sports Exerc. 2001;33:S598.
View In Article|Cross Reference
50.Keysor JJ. Does late-life physical activity or exercise prevent or minimize disablement? A critical review of the scientific evidence. Am J Prev Med. 2003;25:129.
View In Article|Cross Reference
51.Province MA et al. The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. JAMA 1995;273:1341.
View In Article|Cross Reference
52.Manal B et al. Nutrition and frailty: a review of clinical intervention studies. J Frailty Aging. 2015;4:100-106.
View In Article|Cross Reference
53.Moorhouse P et al. Palliative and therapeutic harmonization: a model for appropriate decision-making in frail older adults. J Am Geriatr Soc. 2012;60(12):2326-2332.
View In Article|Cross Reference
54.Domecq JP et al. Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(2):363-370.
View In Article|Cross Reference
55.Ensrud KE et al. Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study. J Am Geriatr Soc. 2011;59:101.
View In Article|Cross Reference
56.Jackson C et al. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. QJM. 2007;100:185.
View In Article|Cross Reference
57.Bischoff-Ferrari HA et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999.
View In Article|Cross Reference
58.Bischoff-Ferrari HA et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692.
View In Article|Cross Reference
59.Gillespie LD et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2009;(2):CD007146.
View In Article|Cross Reference
60.Cameron ID et al. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev. 2010;(1):CD005465.
View In Article|Cross Reference
61.Montero-Odasso M et al. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med. 2005;26:203.
View In Article|Cross Reference
62.Muller M et al. Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men. J Clin Endocrinol Metab. 2006;91(10):3988-3991
View In Article|Cross Reference
63.Serra-Prat M et al. Effectiveness of an intervention to prevent frailty in pre-frail community-dwelling older people consulting in primary care: a randomised controlled trial. Age Ageing. 2017;46(3):401-407.
View In Article|Cross Reference
64.Welsh TJ et al. Comprehensive geriatric assessment–a guide for the non-specialist. Int J Clin Pract. 2014;68(3):290-293.
View In Article|Cross Reference
65.Gill TM et al. A prehabilitation program for the prevention of functional decline: evidence for an expanded benefit. J Am Geriatr Soc. 2003;51:S36-S37.
66.Fu W et al. Severity of frailty as a significant predictor of mortality for hemodialysis patients: a prospective study in China. Int J Med Sci. 2021;18(14):3309-3317.
View In Article|Cross Reference
67.Kojima G et al. Frailty index as a predictor of mortality: a systematic review and meta-analysis. Age Ageing. 2018;47(2):193-200.
View In Article|Cross Reference
68.Rockwood K et al. Limits to deficit accumulation in elderly people. Mech Ageing Dev. 2006;127:494-496.
View In Article|Cross Reference
69.Rockwood K et al. Physiological redundancy in older adults in relation to the change with age in the slope of a frailty index. J Am Geriatr Soc. 2010;58:318-323.
View In Article|Cross Reference
70.Talegawkar SA et al. A higher adherence to a Mediterranean-style diet is inversely associated with the development of frailty in community-dwelling elderly men and women. J Nutr. 2012;142(12):2161-2166.
View In Article|Cross Reference
71.Leon-Munoz LM et al. Mediterranean diet and risk of frailty in community-dwelling older adults. J Am Med Dir Assoc. 2014;15(12):899-903.
View In Article|Cross Reference
72.Bollwein J et al. Dietary quality is related to frailty in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2013;68(4):483-489.
View In Article|Cross Reference
73.Kojima G et al. Adherence to Mediterranean diet reduces incident frailty risk: systematic review and meta-analysis. J Am Geriatr Soc. 2018;66(4):783-788.